Literature DB >> 23754839

A relational understanding of sibling experiences of children with rare life-limiting conditions: findings from a qualitative study.

Cari Malcolm1, Faith Gibson2, Sally Adams3, Gillian Anderson3, Liz Forbat4.   

Abstract

Mucopolysaccharidoses (MPS) and Batten disease are rare life-limiting conditions (LLCs) characterised by progressive and permanent physical and cognitive decline. The impact of such conditions on families, and notably on siblings, has not yet been described or documented. This paper presents data from a UK-wide study that sought to understand the family experience of supporting a child with the rare degenerative LLCs of MPS and Batten disease. The aim of this paper is to report sibling experiences related to these rare degenerative and progressive conditions, in order to inform the future development of supportive interventions. Eight siblings of children with MPS (n = 7) and Batten Disease (n = 1) participated in semi-structured qualitative interviews. A card sort technique was utilised to support and engage the children. Siblings are clearly impacted emotionally, pragmatically and relationally by the ill health of another child in the family. The data indicate four key themes which demonstrate impacts on siblings: perceptions of the condition and its symptoms, impact on daily life, emotional consequences and ways of coping. Siblings often had considerable knowledge of the condition and took on important roles in symptom management. However, these experiences were in the context of managing relationships within the family (often protecting parents from an awareness of how much they knew) and relationships at school (including distraction from learning and being bullied by peers). The data highlight how sibling experiences are generated through a combination of negative disability discourses and support through peers and family members. The data indicate how these features shift as a consequence of witnessing the advancement of their brother's or sister's condition and the emotional sequelae of disease progression. Exploration of siblings' experiences of living with such rare progressive and degenerative LLCs suggest the focus of interventions to support this group should address their emotional health and ways to overcome isolation and build connections with other siblings who share their unique experiences. Critically, the data suggest that sibling support should be cognisant of the trajectory of the illness as well as the family, school and peer relational contexts that siblings inhabit.
© The Author(s) 2013.

Entities:  

Keywords:  Palliative care; qualitative approaches; sibling(s)

Mesh:

Year:  2013        PMID: 23754839     DOI: 10.1177/1367493513485825

Source DB:  PubMed          Journal:  J Child Health Care        ISSN: 1367-4935            Impact factor:   1.979


  5 in total

1.  Using Communication Tools to Explore Young Siblings' Experiences of Having a Brother or Sister with Pediatric Palliative Care Needs.

Authors:  Ulrika Kreicbergs; Stefan Nilsson; Margaretha Jenholt Nolbris; Malin Lövgren
Journal:  Children (Basel)       Date:  2022-04-29

2.  Families with complex needs: an inside perspective from young people, their carers, and healthcare providers.

Authors:  Mădălina Radu; Ramona Moldovan; Adriana Băban
Journal:  J Community Genet       Date:  2022-03-18

Review 3.  The under reporting of recruitment strategies in research with children with life-threatening illnesses: A systematic review.

Authors:  Briony F Hudson; Linda Jm Oostendorp; Bridget Candy; Victoria Vickerstaff; Louise Jones; Monica Lakhanpaul; Myra Bluebond-Langner; Paddy Stone
Journal:  Palliat Med       Date:  2016-09-08       Impact factor: 4.762

4.  Hearing the Voice of a Shadow Child: Healthy Siblings Experience of Cystic Fibrosis and Other Life-Threatening Conditions.

Authors:  Andrew Cox; Colin Pritchard
Journal:  J Patient Exp       Date:  2020-08-14

5.  Psychosocial Functioning in Siblings of Children With Rare Disorders Compared to Controls.

Authors:  Yngvild B Haukeland; Torun M Vatne; Svein Mossige; Krister W Fjermestad
Journal:  Yale J Biol Med       Date:  2021-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.